tirzepatide safety concerns Adverse events associated with tirzepatide: updated pharmacovigilance | DHPS Psychiatric Safety of Tirzepatide: 3

Patients should also contact their provider if they experience symptoms of hypoglycemia (low blood sugar), particularly if taking semaglutide with insulin or sulfonylureas

Ortega FB, Lavie CJ, Blair SN

Types of GLP-1 Medications Offered: Wegovy, Zepbound, Zepbound vials, Mounjaro, Ozempic, Trulicity, Victoza, Saxenda, Accepts Insurance: Yes

In a recent FDA drug safety communication regarding SGLT-2 inhibitor-associated DKA, hypovolemia and acute renal impairment were listed as potential factors that may contribute to the development of a high anion gap metabolic acidosis

Expansion of the private market In most countries, where weight-loss treatments are self-funded, a lower-cost off-patent semaglutide could dramatically increase patient access, for example India and China are price-sensitive and with a dozen manufacturers developing off-patent semaglutide, this could create a surge in demand and expand the private market

10.1146/annurev.pharmtox.46.120604.141254 85 MangalN.ErridgeS.HabibN.SadanandamA.ReebyeV.SodergrenM